UnitedHealth Group CEO Acquires Additional Shares

UnitedHealth Group's CEO, Noel Timothy John, has increased his stake in the company by buying 76 shares on June 23, 2026. This insider transaction was not part of a pre-planned trading scheme. The transaction code 'A' indicates an acquisition.

UnitedHealth Group Incorporated Stock Up 5.7%

Shares of NYSE:UNH traded near $415.53 on Friday. UnitedHealth Group, a leading player in the healthcare sector, boasts a market cap of about $369.32 billion. The company's P/E ratio stands at 30.65, with a forward P/E of 19.43. UnitedHealth's stock has ranged from $234.60 to $415.98 over the past 52 weeks. The 50-day moving average is approximately $372.67, while the 200-day moving average is around $333.55.

Insider Buying and Selling at UnitedHealth Group Incorporated

On June 23, several insiders, including Noel Timothy John, made purchases of UnitedHealth Group shares. Other insiders like Frederick William McNabb III, Paul Garcia, Charles Baker, Christopher Zaetta, Timothy Patrick Flynn, and Stephen Hemsley also acquired shares, with transactions not pre-planned.

Other Institutional Activity in UnitedHealth Group

Institutional investors have been active in UnitedHealth Group. BlackRock, Inc. reduced its holdings by 1,276,021 shares, holding a total of 73,467,531 shares valued at about $19.88 billion. Vanguard Capital Management LLC opened a new position with 58,870,777 shares worth approximately $15.93 billion. Meanwhile, State Street Corp added 100,016 shares, bringing its total to 45,332,186 shares valued at $12.27 billion. Capital World Investors increased its stake by 5,192,373 shares to 27,783,415 shares, valued at $7.52 billion.

Analysts Set New Price Targets

Analysts have maintained a positive outlook on UnitedHealth Group. On June 24, B of A Securities maintained a 'buy' rating with a $475 price target. Other firms like Leerink Partners, Mizuho, and JP Morgan also maintained their 'buy' ratings with targets of $462, $460, and $466, respectively. The consensus among 26 analysts is a 'buy' recommendation, with an average target price of $409.77.

About UnitedHealth Group

UnitedHealth Group Incorporated is a major player in the healthcare industry, offering a wide range of health care products and services. Based in Eden Prairie, Minnesota, the company operates through four segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. Under the leadership of CEO Stephen J. Hemsley, UnitedHealth Group provides care management, pharmacy care services, and health benefit plans to a diverse range of customers, including individuals and employers. The company employs approximately 390,000 people and serves customers both in the United States and internationally.

Bottom Line

The recent insider buying activity by UnitedHealth Group's CEO and other executives reflects their confidence in the company's future. With a strong market position and positive analyst ratings, UnitedHealth remains a key player in the healthcare sector. Investors often track insider transactions for potential insights, but it's important to remember that these filings are backward-looking and may not reflect current conditions.